Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

22.32
-0.2500-1.11%
Pre-market: 22.320.00000.00%08:41 EDT
Volume:1.64M
Turnover:36.92M
Market Cap:1.55B
PE:-24.07
High:23.25
Open:23.25
Low:22.06
Close:22.57
52wk High:29.65
52wk Low:11.46
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.89
T/O Rate:2.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:11.91
PE(LYR):-7.34

Loading ...

Tandem Diabetes Care Is Maintained at Neutral by Citigroup

Dow Jones
·
May 29

Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs

TIPRANKS
·
May 27

Tandem Diabetes Care shareholders approve charter amendments at annual meeting

Reuters
·
May 22

Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook

TIPRANKS
·
May 20

Tandem Diabetes Care Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 19

Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged

TIPRANKS
·
May 15

Tandem Diabetes Care Inc - Company Strategy and 2026 Goals Remain Unchanged - SEC Filing

THOMSON REUTERS
·
May 15

Tandem Diabetes Care Inc - Mark Novara, Evp and Chief Commercial Officer, to Be Terminated Without Cause - SEC Filing

THOMSON REUTERS
·
May 15

Tandem Diabetes Care Inc : Benchmark Initiates Coverage With Hold Rating

THOMSON REUTERS
·
May 12

Tandem Diabetes initiated with a Hold at Benchmark

TIPRANKS
·
May 12

Stock Track | Tandem Diabetes Care Plummets 5.23% Intraday on Analyst Price Target Cuts

Stock Track
·
May 11

Tandem Diabetes Care Is Maintained at Overweight by Barclays

Dow Jones
·
May 11

Tandem Diabetes Care (TNDM) Gets a Buy from Barclays

TIPRANKS
·
May 11

Tandem Diabetes Care Charts Growth Amid Transition

TIPRANKS
·
May 09

Truist Cuts Price Target on Tandem Diabetes Care to $31 From $35, Keeps Buy Rating

MT Newswires Live
·
May 08

Stock Track | Tandem Diabetes Care Soars 8.23% in Pre-market on Strong Q1 Earnings Beat and Improved Outlook

Stock Track
·
May 08

Stock Track | Tandem Diabetes Care Soars 11.53% Intraday on Better-Than-Expected Q1 Results and Improved Outlook

Stock Track
·
May 08

Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained

TIPRANKS
·
May 08

Tandem Diabetes Care Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results

Stock Track
·
May 08